Guangdong Lifestrong Pharmacy Co., Ltd. (SHE:301111)
27.04
-0.66 (-2.38%)
Jun 11, 2026, 2:25 PM CST
SHE:301111 Revenue
Guangdong Lifestrong Pharmacy had revenue of 66.18M CNY in the quarter ending March 31, 2026, a decrease of -6.54%. This brings the company's revenue in the last twelve months to 310.01M, up 11.41% year-over-year. In the year 2025, Guangdong Lifestrong Pharmacy had annual revenue of 314.64M with 12.92% growth.
Revenue (ttm)
310.01M
Revenue Growth
+11.41%
P/S Ratio
14.30
Revenue / Employee
536.35K
Employees
578
Market Cap
4.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 314.64M | 36.00M | 12.92% |
| Dec 31, 2024 | 278.64M | -13.76M | -4.71% |
| Dec 31, 2023 | 292.40M | 9.06M | 3.20% |
| Jan 1, 2023 | 283.34M | -66.45M | -19.00% |
| Jan 1, 2022 | 349.79M | 8.83M | 2.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 25.24B |
| Jianmin Pharmaceutical Group | 3.35B |
| Zhejiang Starry Pharmaceutical | 2.47B |
| Luoxin Pharmaceuticals Group Stock | 2.37B |
| Yabao Pharmaceutical Group | 2.20B |
| Hunan Fangsheng Pharmaceutical | 1.79B |
| Fuan Pharmaceutical (Group) | 1.68B |
| Tianjin Lisheng Pharmaceutical | 1.35B |